Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VISX -- Ignore unavailable to you. Want to Upgrade?

To: straight life who wrote (1480)	1/14/2000 10:20:00 AM
From: Robert G. Harrell	Read Replies (2) \| Respond to of 1754

Please correct me if I'm wrong, but doesn't this article have the patent suit information bass ackwards? California-based VISX designs and develops technology for laser vision correction, and the market maker noted some concern about competitive pricing pressures in that industry as well as continued uncertainty about a patent infringement case against VISX by rival laser systems developer Nidek Inc. I thought VISX brought suit against Nidek. If my foggy memory is correct, this is a perfect example of how screwed up the conventional wisdom is about this company. Speaking of foggy memory, I wasted much time yesterday searching for the comment about Michael Murphy's fund performance and could find nothing. Perhaps it was only in the print version and I was searching the online versions or maybe I'm just wrong. I'm fighting a cold right now and just can't work up the energy to page through back isssues. Murphy's ads claim "recommended investments up 60% in the first 9 months of 1999" "553%return over 10 years" "rated #1 technology advisor by an independent industry watchdog." Regardless of his track record, let's hope he's wrong on this one. Bob